Skip to main content

Table 1 Characteristics of the study groups

From: Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1

 

AMI (n = 27)

UAP (n = 26)

SAP (n = 38)

Control (n = 39)

Age (years ± SEM)

65 ± 14

72 ± 12

66 ± 10

67 ± 12

Males n (%)

16 (59)

18 (69)

28 (74)

14 (36)

Hypertension n (%)

12 (44)

23 (88)

34 (89)

28 (72)

Dyslipidemia n (%)

14 (52)

16 (62)

32 (84)

26 (67)

Diabetes n (%)

6 (22)

7 (27)

15 (39)

8 (21)

Smoking n (%)

13 (48)

5 (19)

7 (18)

4 (10)

History of MI n

2

5

12

2

History of stroke n

0

4

4

1

BMI

28.3 ± 3.3

27.9 ± 4.3

28.7 ± 5.3

27.5 ± 4.4

creatinine (μmol/L)

87.7 ± 31.6

88.5 ± 26.5

87.5 ± 26.9

75.3 ± 17.6

treatment n (%):

    

Aspirin

5 (19)

14 (54)

26 (68)

20 (51)

ADP blockers

1 (4)

6 (23)

12 (32)

6 (15)

Beta blockers

4 (15)

10 (39)

25 (66)

20 (51)

ACE inhibitors

2 (7)

16 (62)

22 (58)

12 (31)

ARB

2 (7)

1 (4)

5 (13)

8 (21)

Statins

2 (7)

11 (42)

28 (74)

20 (51)

Ca blockers

1 (4)

5 (19)

11 (29)

6 (15)

Warfarin

2 (7)

2 (8)

4 (11)

2 (5)

  1. AMI acute myocardial infarction, SAP stable angina pectoris, UAP unstable angina pectoris, smoking reflects current smokers, body-mass index (BMI) and serum creatinine are expressed as average values ± standard deviation